U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation
Source: http://feeds.foxnews.com/~r/foxnews/health/~3/amqo_PhhLmQ/
Brak komentarzy:
Prześlij komentarz